Haemonetics
(NYSE) HAE
Haemonetics Financials at a Glance
Market Cap
$3.31B
Revenue (TTM)
$1.33B
Net Income (TTM)
$97.31M
EPS (TTM)
$2.03
P/E Ratio
35.82
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$72.65
Volume
9,403
Open
$73.51
Price
$72.65
Volume
9,403
Open
$73.51
Previous Close
$72.78
Daily Range
$72.30 - $74.63
52-Week Range
$47.32 - $87.32
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$72.65
Volume
9,403
Open
$73.51
Previous Close
$72.78
Daily Range
$72.30 - $74.63
52-Week Range
$47.32 - $87.32
Estimated Earnings Date
Aug 6, 2026
HAE News
HAE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Haemonetics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
3,009
CEO
Christopher A. Simon, MBA
Website
www.haemonetics.comHeadquarters
Boston, MA 02110, US
HAE Financials
Key Financial Metrics (TTM)
Gross Margin
57.34%
Operating Margin
18.15%
Net Income Margin
7.29%
Return on Equity
11.32%
Return on Capital
11.95%
Return on Assets
4.06%
Earnings Yield
2.79%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.31B
Shares Outstanding
45.45M
Volume
9.40K
Avg. Volume
879.33K
Financials (TTM)
Gross Profit
$764.90M
Operating Income
$242.16M
EBITDA
$280.22M
Operating Cash Flow
$293.22M
Capital Expenditure
-$32.78M
Free Cash Flow
$260.44M
Cash & ST Invst.
$245.44M
Total Debt
$1.22B
Haemonetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$346.35M
+4.8%
Gross Profit
$198.21M
+9.0%
Gross Margin
57.23%
N/A
Market Cap
$3.31B
N/A
Market Cap/Employee
$904.45K
N/A
Employees
3,657
N/A
Net Income
-$20.15M
-134.7%
EBITDA
$4.29M
-95.7%
Quarterly Fundamentals
Total Cash
$245.44M
-20.0%
Total Debt
$1.22B
-0.0%
Accounts Receivable
$216.86M
+7.0%
Inventory
$306.37M
-16.1%
Long Term Debt
$1.22B
+32.4%
Short Term Debt
$5.02M
-98.3%
Return on Assets
4.06%
N/A
Return on Invested Capital
11.46%
N/A
Free Cash Flow
$53.28M
-47.2%
Operating Cash Flow
$70.94M
-39.1%